RP-HPLC Method for Estimating Nebivolol and Hydrochlorothiazide
Author Information
Author(s): Meyyanathan S. N., Rajan S. Muralidharan S., Birajdar Arunadevi S., Suresh B.
Primary Institution: J. S. S. College of Pharmacy, Ootacamund, India
Hypothesis
The study aims to develop a validated RP-HPLC method for the simultaneous estimation of nebivolol and hydrochlorothiazide in tablets.
Conclusion
The developed RP-HPLC method is accurate, precise, and suitable for quality control of nebivolol and hydrochlorothiazide in combined dosage forms.
Supporting Evidence
- The method was validated according to ICH guidelines.
- Recovery studies showed an average recovery of 98.25% for nebivolol and 98.65% for hydrochlorothiazide.
- The method demonstrated good linearity with R2 values of 0.998 for nebivolol and 0.9995 for hydrochlorothiazide.
- The limit of detection was found to be 10 ng/ml for nebivolol and 5 ng/ml for hydrochlorothiazide.
- The method was shown to be rugged and robust across different instruments and conditions.
Takeaway
The researchers created a new way to measure two heart medications in tablets quickly and accurately.
Methodology
A reverse phase high pressure liquid chromatographic method was developed and validated for accuracy, precision, linearity, limit of detection, and limit of quantitation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website